Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ADA ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0" "Cell line enriched" "Detected in many" 8 "MOLT-4: 197.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 64.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" 650000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavourable (6.77e-5)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 8.1 3.2 2.5 5.4 6.5 5.3 5.1 0.9 5.0 2.8 7.4 5.0 1.8 142.2 1.7 3.4 4.6 2.4 3.0 9.2 2.7 0.8 1.3 2.1 2.8 8.9 3.6 2.3 1.2 2.4 0.8 0.3 1.8 3.9 1.8 1.5 0.7 2.6 1.3 2.0 2.8 5.0 2.1 1.3 9.5 19.7 1.6 6.1 99.0 2.8 2.1 7.6 3.6 2.6 1.3 41.6 0.5 64.0 16.9 10.3 9.6 1.4 3.9 2.0 1.3 3.9 5.4 3.3 1.4 0.8 1.4 1.0 1.8 1.5 4.0 1.7 1.8 0.2 1.4 5.8 0.8 0.3 1.8 0.8 0.7 1.4 1.6 0.6 2.1 26.1 2.5 0.5 0.9 5.4 2.0 3.3 0.6 3.4 197.1 2.9 0.5 1.4 10.6 2.8 9.8 0.2 0.0 0.0 0.9 2.1 0.4 2.5 0.4 1.9 1.7 1.0 2.0 2.2 0.2 4.3 2.7 8.3 0.3 3.3 0.9 0.0 1.8 0.2 8.7 30.7 5.7 1.3 7.3 10.3 6.8 1.0 5.7 8.1 0.5 16.9 64.0 41.6 5.3 9.6 2.5 6.5 0.9 5.0 2.7 0.8 3.6 2.3 3.9 6.1 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: " "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 19.7 0.0 1.3 28.1 32.0 0.0 2.4 5.0 0.8 0.4 0.0 8.8 0.0 3.3 18.5 14.2 0.0 28.1 0.4 0.0 0.1 0.0 13.0 0.1 2.6 0.0 0.9 4.1 70.8 2.8 30.2 12.3 0.0 0.0 14.2 1.6 0.0 0.0 0.0 9.7 0.0 1.3 0.0 19.2 0.0 0.1 0.1 10.4 0.0 0.4 1.3 0.0 31.7 6.8 4.2 7.7 2.1 0.0 0.0 0.0 20.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: , CAB068175: , HPA005680: , HPA050556: " "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (5.97e-7)" "prognostic unfavourable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavourable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 67.1 14.1 11.7 8.9 1.6 4.1 12.7 42.4 24.8 51.2 38.4 9.6 20.8 3.4 12.3 21.4 34.6 9.2 24.8 98.4 2.2 6.7 4.6 15.9 8.0 0.2 6.6 5.4 0.9 1.1 33.3 22.0 15.9 9.7 7.1 41.7 10.1 5.6 7.7 13.0 15.0 4.1 35.3 2.2 11.3 11.0 5.0 5.9 22.3 25.9 3.9 17.5 7.6 15.1 32.1 36.1 18.9 49.5 3.0 4.7 6.2 10.9 10.7 67.3 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 ASF1A "CIA, DKFZP547E2110" ENSG00000111875 "Anti-silencing function 1A histone chaperone" Q9Y294 6 118894220-118909167 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030502, HPA071495" Enhanced Nucleoplasm Nucleoplasm "HPA030502: , HPA071495: " "unprognostic (7.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.78e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (5.02e-7)" "unprognostic (8.28e-2)" "unprognostic (8.42e-2)" "unprognostic (8.37e-3)" "unprognostic (3.28e-2)" "unprognostic (4.95e-1)" "unprognostic (9.07e-3)" "unprognostic (2.90e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (5.09e-3)" 7.8 14.1 21.5 9.1 23.8 7.9 14.4 20.3 17.5 12.9 10.4 12.6 16.1 8.5 12.3 15.6 13.7 12.3 9.0 14.6 18.1 19.2 14.4 13.3 15.0 16.3 21.6 14.9 20.9 10.8 25.7 12.9 9.5 15.2 12.0 12.5 9.1 11.6 15.4 16.6 12.9 11.7 11.6 21.4 15.2 11.8 10.5 14.8 36.9 20.2 14.9 16.4 13.3 12.2 13.4 12.8 12.2 7.9 12.1 30.8 17.6 6.2 4.0 14.2 9.4 12.2 7.2 11.4 8.5 8.5 11.1 12.6 5.0 5.4 10.5 14.0 6.0 6.9 12.2 10.9 14.3 7.5 11.3 15.4 9.7 31.7 8.5 25.9 8.0 6.3 11.1 9.6 14.7 14.7 23.8 28.1 13.1 6.5 30.3 20.5 5.9 13.8 16.6 5.8 13.0 14.9 8.1 9.1 7.0 8.6 8.8 9.9 5.0 24.3 12.7 5.2 7.7 7.1 13.0 8.7 14.5 15.3 13.6 20.7 11.2 6.6 6.0 12.2 16.3 6.3 22.7 13.4 26.6 20.9 12.8 8.1 29.1 23.8 1.0 12.1 7.9 9.7 30.8 17.6 21.5 23.8 20.3 17.5 18.1 19.2 21.6 14.9 15.2 14.8 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97852118-97872542 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;T-cells: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavourable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavourable (8.79e-5)" "prognostic unfavourable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavourable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 6.5 7.5 15.9 10.9 21.4 7.6 9.9 31.7 32.3 5.7 10.1 9.4 5.6 6.5 10.0 19.9 10.2 6.9 6.8 9.2 24.5 20.4 6.5 5.9 9.6 16.0 16.3 13.4 19.2 68.0 16.7 16.7 3.2 35.9 9.2 12.7 4.4 49.9 9.3 3.5 13.6 7.8 11.3 20.6 11.0 20.8 16.9 9.2 3.6 16.7 8.2 15.0 9.6 6.6 8.6 1.4 1.5 1.2 2.2 13.2 3.2 18.8 7.2 7.3 59.3 5.8 8.2 17.9 13.9 8.9 6.7 19.9 9.3 7.6 14.8 7.0 28.3 8.6 18.9 22.0 15.9 18.5 14.0 4.7 3.6 6.9 53.7 30.2 13.3 16.1 74.0 8.7 53.8 5.4 26.5 52.6 10.4 39.9 0.8 8.0 10.0 19.7 2.3 1.3 38.8 4.3 3.7 31.9 24.0 3.6 19.3 75.0 8.2 21.2 1.4 3.3 21.8 8.7 6.5 62.4 31.1 56.4 41.2 13.8 31.7 1.5 0.3 0.5 3.8 1.2 4.9 8.6 7.4 3.4 1.4 6.2 10.2 5.5 1.5 2.2 0.8 0.1 13.2 3.2 15.9 21.4 31.7 32.3 24.5 20.4 16.3 13.4 35.9 9.2 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB056158: , HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.0 9.8 13.9 4.7 2.5 3.2 6.1 19.7 6.8 17.0 19.0 7.4 10.9 16.4 6.0 6.2 12.0 18.6 6.3 27.3 22.8 9.9 29.5 10.5 15.0 1.0 10.8 14.6 1.0 0.9 16.1 5.4 5.2 13.8 16.8 12.6 26.0 30.9 8.1 2.5 9.8 16.2 16.6 8.9 6.0 11.5 17.9 7.8 28.5 74.4 5.0 15.1 10.2 3.2 12.9 17.8 10.2 23.6 5.4 9.6 15.2 8.4 18.1 10.1 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell line enhanced" "Detected in many" "BEWO: 43.4;HDLM-2: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA001562 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.6 0.4 13.4 2.8 1.3 3.4 43.4 4.8 3.9 4.1 9.9 8.9 5.0 0.1 2.2 0.3 3.7 8.0 1.3 6.8 31.7 7.7 0.5 3.9 3.1 24.6 2.8 7.5 6.0 21.6 11.5 26.9 0.8 3.1 25.3 0.6 0.8 8.5 1.8 9.6 2.8 2.5 8.9 5.7 0.5 0.9 6.0 6.1 6.2 11.2 18.8 6.5 2.0 0.8 1.2 6.4 4.0 2.1 20.0 8.4 2.2 4.0 1.5 3.5 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "CAB005862: AB_449204, HPA037708: " "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.0 28.2 42.0 20.2 0.9 1.4 16.1 19.7 10.6 40.8 37.7 36.5 12.4 41.0 10.2 7.8 30.2 30.5 13.5 33.8 18.0 50.1 24.4 16.1 30.8 0.1 12.9 24.0 0.7 0.6 23.9 15.0 18.8 15.2 15.9 17.9 19.5 46.8 18.3 26.1 12.6 31.7 38.7 17.0 8.9 8.1 9.1 13.0 17.5 7.9 13.4 13.8 8.7 7.3 16.4 16.9 14.7 51.2 11.6 7.7 30.8 7.9 19.6 33.1 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008419 Supported Cytosol Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavourable (7.43e-6)" "prognostic unfavourable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.6 11.0 35.1 13.9 0.8 2.5 11.3 20.5 11.5 22.0 19.1 16.0 8.3 19.6 11.5 7.4 24.4 33.1 11.1 24.0 16.8 17.8 28.6 28.4 14.9 0.0 25.7 15.7 0.5 0.6 13.4 12.7 15.9 24.6 20.9 21.9 7.3 20.2 15.7 23.7 12.5 21.7 28.8 14.8 6.7 11.0 22.9 14.1 12.7 12.1 4.5 14.1 13.4 9.2 16.9 17.9 16.8 18.2 10.9 18.5 32.0 9.0 29.0 21.9 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: , HPA061448: " "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.54e-7)" "prognostic unfavourable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.7 40.7 55.8 49.6 2.9 5.0 131.9 26.0 19.5 68.7 58.1 60.1 55.4 36.1 31.7 24.0 37.1 56.1 56.9 77.1 35.4 27.8 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.4 27.5 36.6 27.7 28.7 55.9 55.9 27.3 23.8 31.1 25.8 28.7 40.3 37.0 25.1 21.7 28.4 17.9 44.8 21.1 19.3 40.3 20.9 15.4 15.3 49.8 27.6 65.0 14.4 26.6 50.4 21.2 35.0 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641087-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 94.3;WM-115: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Nucleoplasm "CAB000024: AB_563678, HPA027802: " "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavourable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavourable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 52.0 11.6 9.7 6.0 9.7 0.7 22.8 3.4 7.7 15.4 8.9 15.4 19.9 8.4 18.8 23.1 37.7 11.8 31.0 23.9 10.8 8.8 14.5 68.1 22.2 3.7 12.4 5.6 6.5 31.5 83.2 16.6 38.1 10.0 30.7 6.8 24.8 25.6 21.7 2.0 43.6 10.4 16.5 12.6 12.9 19.2 4.0 7.5 9.0 17.1 23.1 23.6 21.4 22.1 3.0 3.4 0.8 0.0 0.0 0.9 0.3 47.6 19.1 6.3 0.1 19.6 20.7 13.7 75.6 28.1 8.8 5.2 21.4 37.0 0.0 34.3 39.3 34.9 0.6 20.5 15.9 0.1 3.8 0.0 4.7 21.7 4.7 0.3 0.7 11.7 4.0 12.4 4.8 15.1 0.0 0.1 69.5 20.2 0.0 2.7 11.6 21.1 0.1 20.2 1.1 41.0 29.5 1.0 25.0 0.9 17.9 47.0 10.9 0.9 63.0 43.4 12.1 18.8 51.3 94.3 56.3 0.1 37.1 0.6 131.3 0.8 0.0 0.0 0.9 0.0 0.1 3.0 0.4 0.2 3.4 2.5 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.3 9.7 9.7 3.4 7.7 10.8 8.8 12.4 5.6 10.0 7.5 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favourable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavourable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.7 13.9 13.0 10.8 1.1 2.0 8.6 16.5 9.8 14.5 14.5 11.9 6.8 17.5 7.1 6.8 13.5 18.0 8.4 21.4 6.5 5.2 17.9 10.1 6.4 0.2 7.9 8.7 1.1 0.5 10.1 6.9 10.4 14.0 20.2 13.2 5.8 22.2 3.7 13.3 6.2 11.4 14.4 6.4 4.1 8.0 5.5 5.9 14.0 6.8 6.5 7.5 3.9 7.2 10.8 17.3 20.3 15.2 3.4 6.9 18.5 7.7 10.4 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavourable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 5.9 2.1 14.2 16.0 11.7 12.5 27.6 7.6 3.6 10.3 28.3 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.3 5.9 2.7 0.9 7.7 6.4 6.4 14.9 6.3 4.1 7.9 61.8 40.7 21.1 5.3 43.7 13.6 17.5 6.8 8.7 5.2 9.2 9.3 3.1 5.0 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.7 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687339 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 97.4;HSkMC: 71.6;hTCEpi: 92.6;LHCN-M2: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 21.0;non-classical monocyte: 27.7" "Group enriched" "Detected in many" 8 "B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: " "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favourable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favourable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 81.2 27.0 8.2 21.9 29.8 22.0 38.0 4.8 13.7 25.2 60.8 13.9 10.2 39.8 17.5 17.7 63.5 49.4 47.3 35.9 22.2 8.4 29.1 102.2 55.8 6.3 16.6 4.9 59.1 45.5 12.8 22.8 38.6 44.1 42.0 40.7 8.8 18.0 11.4 98.6 43.5 144.9 40.2 29.6 13.6 25.2 25.3 10.3 6.6 22.7 42.2 27.4 50.5 44.4 8.8 8.5 1.8 27.7 0.2 1.1 13.3 3.0 12.4 9.6 0.2 33.8 60.5 17.6 50.3 40.8 6.2 24.5 1.1 2.9 2.0 1.8 31.5 6.9 0.4 55.5 10.1 4.0 2.5 0.3 10.3 15.4 97.4 0.0 15.1 71.6 92.6 57.1 18.0 32.4 0.5 14.2 72.2 6.4 0.4 1.2 1.2 1.8 6.1 7.9 3.5 11.0 23.1 4.3 4.2 11.6 1.0 2.3 3.8 12.6 17.9 10.9 10.3 0.7 4.1 23.9 4.6 6.1 14.1 1.1 30.3 0.0 9.3 0.2 0.2 21.0 0.3 8.8 0.4 0.3 8.0 5.7 0.1 0.1 1.8 0.2 27.7 8.5 1.1 13.3 8.2 29.8 4.8 13.7 22.2 8.4 16.6 4.9 44.1 10.3 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Nucleoplasm "CAB070134: AB_2229328, HPA052382: , HPA064308: " "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavourable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavourable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.2 18.3 39.5 20.6 1.5 2.0 15.4 20.0 8.2 12.0 11.9 14.5 20.0 30.8 11.9 11.1 20.1 24.3 13.1 20.5 26.8 15.3 25.3 28.1 20.7 0.2 35.7 13.8 0.7 1.0 17.3 20.0 12.6 22.7 18.4 21.5 12.3 21.1 14.3 35.0 8.1 22.5 55.8 10.1 11.8 8.0 18.5 25.2 27.0 18.0 10.4 21.5 13.7 16.5 21.9 25.8 18.1 41.3 14.2 15.3 29.6 9.5 25.8 19.3 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12804017 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.6" "Cell line enhanced" "Detected in many" "Hep G2: 44.4;HMC-1: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 93.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" 380000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: " "prognostic unfavourable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favourable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 10.9 11.5 8.3 14.3 14.3 9.5 8.5 2.7 11.8 9.2 13.8 20.8 7.4 16.3 8.2 6.2 23.1 7.2 8.9 10.7 11.2 9.5 26.2 31.4 10.4 21.2 20.7 7.7 6.4 4.1 4.3 6.5 36.6 17.6 9.1 11.9 10.2 15.1 7.3 6.4 6.8 20.5 10.0 22.1 27.4 8.1 18.2 13.1 5.8 11.1 8.4 16.9 9.8 9.6 1.5 23.1 93.6 43.7 1.9 1.8 14.6 1.5 9.3 1.0 2.4 3.9 8.4 0.1 17.0 4.6 9.2 7.5 4.5 4.8 2.2 17.7 12.4 0.1 0.0 4.2 9.5 5.2 2.6 19.3 1.4 44.4 2.4 0.0 42.0 8.4 0.9 0.8 6.6 13.7 6.7 1.4 22.4 1.9 1.7 8.9 2.8 1.3 3.6 6.0 4.8 13.8 2.9 4.9 3.2 0.0 15.5 6.1 3.3 4.2 20.4 13.2 2.7 0.0 0.0 0.0 0.3 3.5 2.9 9.8 2.8 6.1 30.6 19.3 1.3 43.7 1.1 1.5 1.1 1.4 23.1 1.0 0.3 0.8 93.6 1.9 40.6 5.6 1.8 14.6 8.3 14.3 2.7 11.8 11.2 9.5 20.7 7.7 17.6 13.1 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol 64000 "Nucleoplasm, Cytosol" "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavourable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavourable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavourable (6.91e-4)" 15.7 18.9 19.5 18.7 23.7 13.7 21.2 24.9 31.3 17.5 14.2 13.4 14.0 12.0 19.5 15.5 25.5 17.3 11.8 17.8 20.0 17.7 18.8 18.7 12.8 24.0 27.3 19.4 18.7 17.3 23.2 16.8 23.1 24.2 16.7 18.4 8.4 15.5 17.0 34.3 20.9 12.4 21.7 31.3 12.6 17.1 50.9 21.0 27.0 14.7 28.1 25.3 18.3 17.5 12.8 14.8 9.4 15.9 16.8 18.0 12.8 35.5 24.8 30.3 23.3 11.8 15.2 32.9 28.1 14.9 88.5 37.5 81.0 28.8 36.5 37.7 17.8 41.3 44.5 52.8 84.5 5.9 21.6 25.3 29.1 39.2 7.2 27.8 13.9 8.5 19.8 43.2 25.1 29.2 35.7 14.4 33.1 12.2 33.5 14.4 25.5 37.0 21.4 49.9 28.4 19.4 24.9 26.7 15.5 44.9 48.7 16.0 40.6 18.2 18.8 47.1 39.6 27.7 39.8 8.4 20.4 34.2 28.1 22.5 25.0 9.4 11.8 2.7 11.0 15.2 16.5 12.8 16.8 13.4 14.8 10.4 18.0 15.3 3.3 16.8 15.9 6.6 14.4 12.8 19.5 23.7 24.9 31.3 20.0 17.7 27.3 19.4 24.2 21.0 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.3 14.2 13.6 10.6 9.8 8.1 21.5 9.8 10.3 23.6 20.9 52.9 12.4 17.1 14.4 9.9 16.5 18.2 23.2 25.5 8.2 9.1 56.1 7.8 25.8 10.2 17.7 74.6 8.6 13.8 13.3 13.3 14.1 15.1 7.0 12.6 12.7 28.7 23.6 12.2 20.6 20.2 26.3 12.9 10.3 12.9 10.9 13.0 17.0 24.5 17.2 12.0 14.3 10.4 23.7 14.1 15.5 15.9 8.2 10.4 19.9 16.6 11.1 12.5 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm Nucleoplasm "HPA054422: , HPA060360: " "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 26.9 32.9 23.2 51.1 31.8 69.0 31.9 31.7 27.6 26.8 26.3 24.4 27.2 14.5 29.8 31.8 33.7 26.9 28.2 35.5 23.2 26.5 25.4 19.8 25.7 44.7 25.3 23.6 33.4 22.2 23.7 30.7 26.0 22.5 30.3 24.3 28.1 27.5 26.1 25.6 27.3 22.6 25.6 23.9 30.1 25.8 31.9 20.7 120.3 40.5 37.7 43.2 23.5 28.4 34.5 32.3 17.0 24.5 22.2 40.2 24.3 25.6 8.1 19.7 18.7 13.8 14.8 11.7 27.2 17.4 25.2 31.3 9.3 17.7 71.6 14.7 14.9 35.3 20.6 18.6 24.7 50.4 21.3 58.4 21.3 12.6 7.7 61.2 27.8 9.0 12.7 17.0 9.0 16.7 31.6 40.7 18.5 10.4 54.7 72.1 12.4 15.6 44.6 43.2 75.2 16.5 17.4 28.6 29.1 20.2 16.4 23.3 23.1 48.9 13.8 26.4 25.5 31.4 35.7 32.9 68.3 70.5 20.0 105.1 28.9 11.3 19.5 17.0 21.7 19.3 28.1 34.5 38.9 34.2 28.2 31.6 40.2 26.5 11.1 22.2 24.5 32.3 34.4 24.3 23.2 31.8 31.7 27.6 23.2 26.5 25.3 23.6 22.5 20.7 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443158-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA037880: " "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favourable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 18.7 15.6 22.0 20.7 22.4 19.1 16.5 20.1 28.6 18.1 22.4 22.5 22.3 18.3 22.2 14.9 26.3 19.0 20.9 20.8 22.5 17.3 15.9 14.1 15.6 18.8 23.3 29.5 21.6 23.5 20.8 18.0 17.9 22.7 17.6 13.3 14.5 23.9 20.2 47.5 24.9 17.1 26.7 16.2 18.2 20.8 40.7 21.0 13.3 19.8 20.7 17.4 20.8 17.6 3.6 3.5 31.0 6.2 9.8 6.4 4.4 12.5 21.2 7.1 15.9 12.3 10.6 17.8 11.2 11.6 11.3 13.7 10.6 18.6 10.7 17.4 14.0 14.3 5.7 9.7 8.3 39.3 9.9 11.5 44.4 8.0 11.5 17.2 29.2 10.8 7.2 12.6 11.1 12.6 8.7 7.0 8.7 14.9 12.3 20.5 5.9 12.7 10.1 8.2 13.7 9.5 15.8 7.2 9.1 27.9 15.8 10.8 21.4 19.9 9.4 11.2 13.9 8.6 9.0 11.9 8.6 7.6 11.8 20.9 10.1 5.4 5.7 31.0 6.4 6.2 5.4 3.3 5.0 5.1 3.5 3.6 6.4 5.9 7.9 9.8 4.4 2.6 6.4 4.4 22.0 22.4 20.1 28.6 22.5 17.3 23.3 29.5 22.7 21.0 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell line enhanced" "Detected in many" "SK-BR-3: 152.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavourable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.1 24.3 11.3 7.8 18.3 12.4 24.2 4.6 6.0 4.9 9.0 25.4 15.8 7.7 3.8 3.5 19.4 10.9 21.3 0.9 3.6 47.4 16.0 18.2 33.9 5.2 8.6 2.4 11.9 5.6 12.5 2.9 5.5 24.1 6.9 1.7 40.1 9.4 13.7 21.9 14.2 8.3 6.4 15.3 5.5 29.7 28.1 15.6 6.8 152.8 12.4 27.2 16.5 9.6 7.2 14.8 5.9 11.0 9.3 2.0 8.0 4.3 9.4 10.6 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FK506 binding protein 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.2" "Cell line enhanced" "Detected in many" "ASC diff: 101.4;ASC TERT1: 63.1;HHSteC: 79.4;HSkMC: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: " "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 78.8 20.7 9.5 14.2 15.6 4.9 36.7 2.4 10.9 16.5 29.0 5.1 29.8 2.2 18.6 16.9 29.2 19.4 17.9 26.3 10.6 4.2 44.9 30.7 19.7 55.9 15.7 3.6 27.2 43.7 8.6 33.8 6.0 13.1 18.3 8.2 11.8 30.4 25.1 277.2 20.2 36.7 18.6 18.2 32.3 25.0 14.3 12.4 20.1 24.2 9.8 16.8 22.5 18.4 4.0 30.6 24.9 31.2 11.8 42.3 39.9 4.9 2.1 9.5 14.2 101.4 63.1 0.1 2.7 0.1 1.7 4.1 3.7 0.8 24.5 2.5 0.5 0.0 5.6 11.9 4.2 9.6 5.3 10.5 1.8 5.2 79.4 6.6 1.0 95.9 48.2 3.1 29.1 10.3 11.2 10.0 18.6 3.1 27.3 12.4 2.4 1.6 12.2 2.4 11.9 7.9 3.0 3.6 2.2 2.2 2.5 0.5 14.0 7.8 22.7 2.5 2.2 0.3 3.7 4.5 5.2 31.1 0.8 12.9 0.9 13.7 31.2 19.4 20.0 27.0 23.8 3.0 28.2 20.8 30.6 4.0 42.3 30.2 24.9 11.8 12.0 9.2 10.3 39.9 9.5 15.6 2.4 10.9 10.6 4.2 15.7 3.6 13.1 12.4 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FK506 binding protein like" Q9UIM3 6 32128707-32130291 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA043478: , HPA060158: " "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favourable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.6 5.6 4.1 2.7 4.7 4.6 7.1 12.1 6.2 4.4 4.5 3.9 8.9 6.0 4.1 8.7 12.7 7.0 4.5 6.0 4.1 3.5 5.9 6.7 4.5 7.7 7.1 2.4 7.0 13.2 6.2 5.0 6.9 5.8 3.8 4.9 3.7 8.0 3.6 5.1 11.5 4.4 5.1 3.6 7.8 6.6 7.6 6.8 10.5 11.6 2.8 6.8 4.7 6.3 3.4 3.7 8.3 4.8 3.3 4.6 1.5 0.0 2.0 4.4 11.9 6.6 4.7 3.8 2.9 3.3 5.5 5.3 9.5 4.0 3.3 3.4 5.0 2.2 6.2 5.7 3.8 5.9 7.6 0.0 6.6 5.3 3.7 0.0 3.6 4.6 5.8 10.7 6.7 5.8 11.1 8.2 5.6 3.2 3.6 4.1 3.3 1.7 3.0 5.8 7.2 5.7 0.7 8.4 2.0 2.9 5.3 6.3 9.2 6.4 2.5 8.0 6.6 4.1 7.0 4.4 7.7 3.0 3.1 5.4 4.9 4.9 3.4 2.3 4.6 4.8 4.4 2.8 2.6 3.3 3.7 3.4 3.0 2.9 8.3 3.3 2.5 2.9 1.1 1.5 4.1 4.7 12.1 6.2 4.1 3.5 7.1 2.4 5.8 6.8 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell line enhanced" "Detected in many" "BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favourable (8.69e-4)" "prognostic favourable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favourable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.6 0.0 1.2 0.8 2.2 0.9 0.6 13.2 3.3 0.1 2.0 5.7 0.9 0.0 5.1 4.9 0.3 0.2 1.9 5.6 0.0 1.2 1.4 1.6 1.9 0.0 0.4 0.8 0.0 0.0 6.8 7.1 0.2 1.1 4.5 5.8 1.4 0.0 1.6 2.7 5.8 29.3 2.4 1.5 0.7 5.6 1.6 0.2 0.1 1.9 3.7 2.3 5.6 4.2 3.2 2.4 4.5 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: , HPA054597: " "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favourable (4.13e-4)" "prognostic unfavourable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavourable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.5 14.6 37.0 15.2 5.2 5.6 24.7 24.1 12.8 29.0 31.9 28.2 8.8 24.7 30.8 7.7 14.4 31.9 17.7 31.3 9.1 33.4 33.8 25.9 46.2 4.9 26.2 12.4 4.5 5.8 17.6 6.9 14.2 42.5 13.1 20.4 19.2 49.2 28.4 20.2 11.5 28.7 28.9 31.7 12.2 21.4 29.7 18.3 10.8 17.8 21.2 18.7 16.1 7.0 17.8 18.0 20.5 40.8 14.6 45.0 46.3 5.4 49.6 25.5 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli,Nuclear bodies" Nucleoli "Nuclear bodies" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavourable (6.11e-4)" "prognostic unfavourable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 27.7 28.0 14.8 21.8 17.5 13.0 40.5 17.2 25.4 25.0 27.0 10.0 22.8 21.6 22.2 17.5 41.8 17.4 16.1 20.5 21.6 15.9 19.3 50.4 19.5 26.6 18.4 15.7 27.2 45.1 14.1 43.3 24.7 23.4 28.3 27.0 8.8 30.3 27.3 52.2 24.1 21.2 19.5 19.6 32.0 22.7 15.0 16.9 18.3 18.1 34.3 35.8 44.3 24.9 16.2 21.6 1.8 8.9 13.6 19.4 10.0 21.2 15.9 23.4 25.0 22.3 22.7 35.8 26.3 20.9 28.1 21.1 24.0 15.6 49.8 8.7 20.2 15.5 38.4 25.1 37.8 31.1 27.4 38.0 27.2 36.8 46.4 54.1 28.3 20.1 44.7 30.4 47.5 22.1 41.8 26.6 19.1 15.2 32.4 30.2 40.2 31.3 19.3 19.0 61.6 22.1 29.8 16.7 21.4 16.4 37.7 36.8 14.9 30.7 17.0 18.8 20.0 27.4 54.9 29.4 47.5 75.5 20.1 39.5 29.7 0.6 8.0 1.8 11.3 8.9 19.4 16.2 15.3 13.4 13.9 13.5 17.7 16.6 1.0 13.6 6.4 21.6 9.7 10.0 14.8 17.5 17.2 25.4 21.6 15.9 18.4 15.7 23.4 16.9 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell line enhanced" "Detected in many" "HHSteC: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.5 2.4 3.0 8.0 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.5 33.4 0.1 0.3 7.1 19.2 5.5 22.7 4.0 6.9 0.0 8.7 11.8 1.2 8.2 10.3 6.1 12.6 7.5 8.8 14.9 6.5 10.7 14.5 9.8 17.9 8.7 10.6 9.4 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria Mitochondria "HPA034831: AB_10671506, HPA058631: " "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favourable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.2 8.8 11.7 13.1 7.1 12.4 9.3 13.3 11.6 13.7 17.1 15.4 8.3 12.6 7.9 7.3 13.2 15.5 12.9 15.8 5.6 10.8 34.5 8.9 8.0 6.8 22.0 8.5 9.8 9.3 7.5 5.4 12.6 12.2 15.0 13.2 7.6 14.0 10.8 24.0 16.7 12.0 10.7 8.0 9.6 12.2 13.5 13.7 10.8 8.5 17.7 9.6 15.0 7.5 10.0 14.8 3.6 12.4 9.8 12.8 17.7 10.0 18.3 11.0 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: , HPA051647: " "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavourable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.1 15.8 25.0 14.9 2.3 1.7 26.4 29.8 9.1 16.8 14.8 25.0 11.3 18.0 18.0 6.8 27.2 11.8 8.5 4.5 26.5 33.1 36.4 4.3 25.7 2.4 17.9 22.7 1.4 1.8 7.1 4.4 8.4 29.4 29.6 8.0 66.7 40.9 53.6 18.2 33.5 40.0 29.5 8.4 7.6 11.4 26.7 31.7 23.6 13.8 4.1 20.6 13.6 10.3 16.3 43.1 13.2 22.1 8.1 7.9 18.2 3.7 29.2 31.8 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli" Mitochondria "HPA008436: AB_1850757, HPA027261: " "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (3.37e-5)" "prognostic unfavourable (2.46e-4)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavourable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.0 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.6 5.3 2.9 10.1 19.9 18.0 13.2 24.4 12.5 6.7 20.5 18.5 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 11.4 17.4 13.3 33.6 17.2 23.7 18.6 19.2 16.0 18.3 33.8 9.4 9.4 10.3 13.0 8.1 14.7 11.2 10.5 8.4 13.1 8.3 19.8 21.5 14.5 27.6 12.7 10.0 21.4 11.8 12.5 49.2 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: " "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavourable (5.52e-4)" "prognostic unfavourable (1.93e-7)" "prognostic unfavourable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.1 14.5 1.4 2.6 20.2 20.1 9.8 25.2 22.9 27.0 40.8 35.1 19.2 6.2 24.4 31.3 19.0 43.0 31.8 9.7 21.0 9.5 13.1 0.4 18.6 19.4 0.7 1.1 23.6 18.5 14.3 19.8 28.8 26.2 7.7 19.6 10.6 23.4 14.5 21.4 36.3 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 27.6 14.9 9.3 18.1 15.3 14.4 26.9 15.5 25.9 28.3 11.9 28.8 17.3 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 HNRNPA0 "hnRNPA0, HNRPA0" ENSG00000177733 "Heterogeneous nuclear ribonucleoprotein A0" Q13151 5 137745651-137754376 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036569, HPA059404" Enhanced Enhanced Nucleoplasm 110000 Nucleoplasm "HPA036569: AB_10670840, HPA059404: " "unprognostic (5.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.00e-2)" "unprognostic (3.78e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "prognostic favourable (3.74e-4)" "unprognostic (6.86e-2)" "prognostic favourable (1.99e-4)" "unprognostic (2.34e-1)" "unprognostic (4.57e-1)" "unprognostic (2.66e-2)" "unprognostic (7.39e-2)" 25.6 30.9 18.1 31.8 21.4 40.7 62.9 35.2 43.8 27.0 21.2 11.5 17.2 21.0 38.1 26.3 25.7 29.3 29.5 29.1 15.7 18.0 17.4 18.5 40.4 61.2 16.5 22.5 42.7 34.8 15.1 20.4 30.7 16.6 22.1 17.2 20.0 18.6 20.8 38.1 23.2 23.1 33.4 16.8 24.2 24.3 25.7 13.6 50.1 26.2 22.5 21.6 24.8 24.2 5.2 6.1 8.0 4.4 7.8 7.1 1.5 14.6 14.7 28.6 28.8 14.1 9.0 29.4 11.3 9.4 10.2 11.7 27.4 11.6 26.7 16.4 9.6 13.5 15.4 17.5 12.4 13.4 21.5 17.2 9.4 16.6 13.0 15.8 18.4 14.6 12.4 8.0 9.3 14.0 14.0 17.9 10.2 19.0 29.5 21.2 22.3 10.8 35.4 20.9 13.4 10.0 16.9 36.4 29.6 14.5 10.2 19.1 12.8 18.3 13.6 16.3 13.9 9.0 21.4 18.2 14.6 18.9 10.5 18.3 16.0 4.2 2.4 8.0 5.9 4.1 7.1 4.2 5.6 5.9 4.2 5.2 6.1 6.0 2.6 7.8 4.4 6.1 3.2 1.5 18.1 21.4 35.2 43.8 15.7 18.0 16.5 22.5 16.6 13.6 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43451003-43453989 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 130.4;seminal vesicle: 80.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 38.7;WM-115: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040092 Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favourable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavourable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavourable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favourable (2.72e-5)" 16.5 12.5 11.6 12.1 10.1 5.3 12.8 11.3 9.7 14.6 16.5 13.0 130.4 23.4 15.8 14.8 8.4 15.3 16.7 10.9 9.2 10.0 15.9 25.8 17.8 6.7 10.9 9.3 25.1 34.0 13.8 11.2 10.8 9.0 15.6 7.5 15.0 20.8 80.0 8.8 8.4 22.1 13.4 14.3 7.6 14.1 4.5 11.1 4.9 12.8 9.6 6.4 10.7 11.3 3.2 21.6 6.2 1.2 4.8 5.4 3.0 17.2 2.2 0.7 1.2 3.4 6.3 0.0 15.1 13.5 19.0 12.7 8.8 30.1 0.0 1.1 9.7 3.2 0.0 15.9 7.8 4.2 6.2 2.8 7.9 0.0 22.4 0.0 0.0 3.7 4.6 21.5 0.0 38.7 0.2 0.0 12.7 0.3 2.5 2.9 3.2 4.4 13.3 0.0 0.1 13.2 0.6 8.2 6.1 16.8 9.5 3.7 2.4 21.6 17.8 1.2 0.0 3.4 29.3 0.0 0.0 0.0 1.0 4.0 32.8 6.2 1.1 2.4 3.3 0.9 4.1 3.2 5.4 2.6 4.1 2.7 5.1 1.5 0.1 4.8 1.2 21.6 0.5 3.0 11.6 10.1 11.3 9.7 9.2 10.0 10.9 9.3 9.0 11.1 ILF2 NF45 ENSG00000143621 "Interleukin enhancer binding factor 2" Q12905 1 153661788-153671048 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007484 Supported Supported Nucleoplasm 3800000 Nucleoplasm "HPA007484: AB_1079137" "unprognostic (1.97e-3)" "unprognostic (8.68e-2)" "unprognostic (3.44e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-3)" "unprognostic (9.70e-2)" "prognostic unfavourable (5.71e-8)" "unprognostic (2.64e-1)" "unprognostic (4.66e-2)" "unprognostic (3.22e-3)" "unprognostic (1.94e-2)" "unprognostic (3.03e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (2.61e-1)" "unprognostic (4.17e-2)" "unprognostic (2.65e-1)" "unprognostic (2.09e-1)" 35.9 39.2 26.3 32.8 27.1 58.1 43.7 25.6 32.8 34.8 33.8 32.7 23.5 24.2 37.8 39.6 46.0 33.9 27.8 32.0 24.7 28.4 64.1 45.4 35.3 38.1 33.2 29.2 46.5 52.8 38.4 36.8 53.3 30.8 29.9 40.4 25.0 50.4 28.3 49.1 38.5 27.7 34.3 26.7 39.8 33.9 58.0 28.5 117.0 58.5 45.5 54.0 32.1 30.9 49.5 55.4 34.5 39.9 52.4 52.5 76.4 48.4 37.8 66.9 46.9 28.1 26.5 53.5 36.2 41.2 65.4 47.2 55.7 39.6 67.2 55.9 36.0 37.2 79.6 38.5 63.4 36.4 51.7 50.4 30.8 47.6 25.8 78.0 37.4 24.2 22.1 49.9 54.3 60.9 63.1 31.9 54.3 64.6 104.2 34.9 95.5 57.7 75.9 57.9 63.4 31.4 47.0 60.2 55.9 42.2 52.6 42.7 57.5 67.6 37.0 33.8 43.3 30.3 59.6 55.5 77.3 135.6 28.3 48.4 50.9 34.5 39.9 28.7 39.8 38.3 50.1 49.5 46.4 42.9 55.4 40.7 52.5 45.6 3.7 52.4 30.3 53.6 51.0 76.4 26.3 27.1 25.6 32.8 24.7 28.4 33.2 29.2 30.8 28.5 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.1 22.0 22.2 17.7 12.4 15.6 14.3 13.4 17.4 22.4 20.8 19.6 28.8 19.9 18.9 16.7 24.7 47.3 22.6 19.8 17.4 28.7 17.3 16.4 21.2 24.7 17.7 22.3 15.1 22.5 17.0 26.2 24.2 23.7 11.6 15.7 19.3 20.1 17.1 16.2 12.2 17.3 18.7 22.8 17.4 22.7 16.0 12.7 16.2 16.5 22.4 15.4 20.7 11.8 15.5 16.3 13.8 21.2 11.5 21.4 26.9 15.6 32.4 18.0 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favourable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favourable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.5 4.3 12.2 8.4 8.3 13.0 6.1 7.6 10.7 9.7 10.0 4.3 5.9 16.1 5.8 7.9 4.6 14.3 8.0 12.9 8.9 4.9 11.7 8.0 5.2 5.7 14.7 8.3 9.3 9.7 9.9 9.5 8.1 16.6 8.9 9.5 3.7 16.3 10.4 11.4 5.5 6.7 11.6 9.1 6.2 5.6 6.1 10.4 8.8 6.9 6.0 11.4 12.6 9.3 5.5 4.9 14.2 8.6 5.7 16.3 9.9 10.0 14.3 7.9 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031263, HPA050214" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA031263: AB_10602610, HPA050214: " "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavourable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 35.5 7.3 10.7 9.4 2.1 3.6 8.9 14.6 13.4 15.3 16.2 9.6 16.5 13.8 4.6 7.4 18.1 11.8 8.2 20.7 16.6 8.1 14.0 12.7 8.2 0.6 23.8 11.6 1.5 1.2 14.8 15.2 9.8 13.3 15.9 13.6 6.1 13.9 4.6 10.9 7.0 9.7 21.0 6.0 4.8 4.8 3.4 6.1 10.5 4.8 5.5 12.4 6.9 7.7 9.9 9.9 12.8 23.4 4.4 12.0 18.6 9.3 21.2 7.3 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: , HPA068831: " "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavourable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavourable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 24.8 21.6 16.0 15.3 1.0 1.9 9.8 27.3 14.8 39.6 30.9 13.1 19.5 14.6 8.3 14.1 28.8 33.1 10.2 40.3 13.5 15.5 13.7 20.3 8.1 0.6 14.1 12.7 0.9 1.0 18.9 16.0 13.4 9.1 18.3 24.9 11.0 7.9 7.6 19.9 8.7 9.0 35.8 8.1 10.4 12.9 8.2 6.8 31.7 13.9 12.0 13.3 6.4 8.7 24.0 31.9 16.6 40.1 7.1 19.2 13.1 8.4 19.1 21.1 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006219 Supported Nucleoplasm,Midbody,Centrosome "Nucleoplasm, Centrosome" Midbody "HPA006219: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavourable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavourable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 28.7 11.2 25.0 20.0 1.3 2.9 16.8 21.6 15.4 44.2 38.6 18.9 20.8 33.1 10.4 10.6 13.7 25.4 14.5 40.5 21.4 10.9 39.2 19.8 15.7 0.1 28.9 18.2 0.7 1.4 31.5 15.4 14.2 30.9 28.4 27.9 11.2 30.4 17.5 24.4 14.1 24.4 37.8 20.8 7.4 10.4 17.2 12.3 28.7 20.5 18.1 11.8 22.0 8.4 16.1 31.9 17.4 37.8 15.1 15.3 47.8 10.3 28.2 30.9 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 LARS "FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS" ENSG00000133706 "Leucyl-tRNA synthetase" Q9P2J5 5 146113038-146182660 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036424, HPA040881" Supported Enhanced "Nuclear bodies,Cytosol" 14000 "Nuclear bodies, Cytosol" "HPA036424: AB_10670102, HPA040881: " "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-3)" "unprognostic (1.92e-1)" "unprognostic (2.69e-1)" "unprognostic (3.39e-1)" "prognostic unfavourable (3.78e-5)" "unprognostic (8.17e-2)" "unprognostic (2.72e-1)" "unprognostic (6.80e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (2.98e-4)" "unprognostic (2.96e-2)" 32.2 30.1 27.0 25.8 31.2 17.8 38.6 31.8 33.7 25.5 25.3 30.1 23.9 16.8 35.8 31.3 28.5 26.8 16.4 29.0 24.2 22.2 26.5 18.4 20.0 24.8 27.3 26.1 32.0 40.8 35.0 43.0 20.6 31.6 26.3 29.9 19.5 39.9 24.8 55.5 24.1 21.5 32.5 30.9 25.2 24.9 20.5 30.5 25.6 30.8 22.8 28.9 30.9 29.2 21.3 28.0 5.8 18.3 19.0 21.8 11.2 20.4 24.2 28.0 45.9 23.2 30.3 43.6 23.9 17.7 24.2 35.1 25.2 22.4 31.1 14.8 31.4 17.5 47.3 39.3 42.4 26.7 27.8 35.5 30.6 14.6 32.2 50.4 23.5 23.8 39.6 39.6 68.8 33.0 39.4 58.3 26.0 16.9 38.9 30.9 43.4 26.8 30.1 35.3 31.0 18.5 18.5 27.6 34.8 26.0 28.7 60.4 32.6 43.5 32.2 28.3 18.8 25.6 35.7 30.3 44.7 50.9 30.8 53.2 33.0 2.5 13.5 5.8 14.8 18.3 19.8 21.1 16.4 13.6 18.6 21.3 21.8 18.0 1.2 19.0 13.6 28.0 14.8 11.2 27.0 31.2 31.8 33.7 24.2 22.2 27.3 26.1 31.6 30.5 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.6 2.5 1.9 1.7 1.5 4.2 1.4 4.6 5.5 6.6 4.0 1.0 5.4 1.7 10.8 1.0 1.5 3.8 16.5 6.9 0.8 1.5 2.0 1.9 2.4 1.8 0.3 1.9 1.2 4.6 7.0 15.0 6.9 1.7 2.7 5.8 2.8 4.9 1.2 0.4 11.6 1.7 3.1 1.0 10.8 0.6 1.6 1.5 1.5 0.3 0.5 1.6 0.8 11.8 2.0 14.6 3.7 1.1 1.7 1.0 1.3 3.2 2.1 1.5 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Supported Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favourable (2.88e-4)" "prognostic favourable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavourable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.5 10.3 61.7 18.8 29.4 40.0 11.4 23.1 41.2 18.3 32.6 10.2 14.2 7.7 60.6 46.4 7.6 17.5 17.4 13.2 13.8 14.5 16.1 12.2 20.0 25.2 4.1 12.4 52.4 7.3 18.6 9.4 34.8 3.9 9.5 35.0 15.4 9.1 6.9 22.8 12.3 6.1 22.1 11.0 25.1 4.2 9.7 25.1 9.2 10.7 53.4 44.0 7.0 29.9 15.6 24.4 23.3 6.5 6.1 5.1 5.6 22.8 10.8 79.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: " "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.5 15.3 18.2 13.7 0.6 1.1 7.9 14.2 2.2 16.0 16.7 14.9 9.7 20.4 6.5 3.6 15.9 25.5 8.3 14.8 10.6 12.1 25.5 6.8 9.9 0.0 13.0 11.6 0.2 0.3 16.2 1.5 5.2 30.0 14.0 8.6 12.2 30.9 5.6 10.7 3.8 24.5 16.1 12.6 3.6 5.0 3.6 13.8 11.5 8.2 2.1 10.3 9.0 3.1 10.2 19.2 15.3 15.3 4.4 16.9 26.9 6.5 14.4 7.9 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: , HPA070520: " "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.6 4.9 8.7 4.5 9.6 8.8 13.3 3.5 7.1 4.5 4.0 4.6 2.8 4.8 1.5 6.4 1.6 5.2 3.0 4.9 22.8 7.5 17.2 2.0 1.9 6.0 7.9 14.4 14.0 4.6 4.3 3.5 4.5 10.4 8.0 6.8 4.4 7.0 2.8 4.1 3.3 5.5 40.1 2.4 4.9 9.0 8.0 6.3 8.2 5.0 3.6 6.0 4.0 4.9 7.5 5.9 5.1 3.5 9.3 8.0 8.4 4.3 5.0 3.7 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 NOP2 "NOL1, NOP120, NSUN1, p120" ENSG00000111641 "NOP2 nucleolar protein" P46087 12 6556863-6568691 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040119 Supported Supported Nucleoli Nucleoli "HPA040119: AB_10965321" "unprognostic (2.88e-1)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (7.15e-2)" "unprognostic (8.74e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (1.12e-5)" "unprognostic (6.38e-2)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (2.53e-1)" "prognostic unfavourable (2.35e-10)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-3)" 16.5 12.7 14.8 21.7 17.1 30.9 15.3 14.8 14.9 10.8 12.8 6.9 7.3 14.0 15.2 11.4 19.5 15.0 11.2 12.8 11.9 8.7 12.8 31.2 14.0 25.9 14.7 8.9 14.5 21.5 12.1 15.1 12.3 13.8 17.4 14.7 9.0 21.3 9.4 32.6 19.1 15.7 14.7 8.9 23.1 13.4 19.4 13.2 24.7 16.8 18.5 27.2 11.5 17.1 12.6 16.5 3.3 11.5 11.9 20.3 10.9 16.1 26.0 7.1 24.3 9.1 7.8 38.6 14.7 9.5 17.4 15.0 31.7 16.5 34.5 4.0 7.2 20.0 27.2 16.2 16.9 40.7 25.5 33.8 24.8 18.3 12.2 33.3 19.5 7.9 16.0 21.0 32.8 11.7 23.7 5.5 13.8 20.0 17.8 29.0 59.4 14.5 25.4 20.7 16.9 12.7 22.3 5.5 10.9 23.0 25.1 12.1 4.1 16.0 11.0 12.0 16.1 15.5 33.7 7.7 11.2 51.5 11.0 19.1 20.8 1.4 8.2 0.9 14.8 11.5 20.3 12.6 14.1 16.6 16.5 10.1 17.3 17.6 3.3 11.9 10.0 14.5 9.7 10.9 14.8 17.1 14.8 14.9 11.9 8.7 14.7 8.9 13.8 13.2 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA042904: , HPA074847: " "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavourable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavourable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.0 12.4 41.3 19.6 2.2 3.6 13.7 29.6 17.5 32.7 31.7 16.8 19.3 19.2 16.5 11.1 35.7 31.8 14.5 31.4 34.4 15.6 48.7 30.9 15.8 0.6 31.0 21.9 1.0 1.7 17.4 13.4 19.6 26.7 65.4 25.3 9.8 38.3 20.8 21.2 15.4 41.4 44.1 20.7 11.7 11.6 29.9 20.5 40.8 24.0 8.5 36.1 23.0 11.8 25.4 31.9 28.7 52.1 24.3 47.1 61.4 13.3 46.6 43.6 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497066-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 203.3" "Cell line enhanced" "Detected in many" "LHCN-M2: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Actin filaments" Cytosol "CAB070159: AB_1726016, HPA035905: " "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.28e-4)" 17.3 8.9 8.5 19.6 7.5 0.1 28.1 2.1 6.7 58.4 71.9 5.7 46.4 6.7 82.2 25.6 84.3 31.3 30.8 95.0 9.2 3.2 12.7 3.6 24.9 17.0 4.6 4.7 28.0 3.0 25.6 3.9 14.0 6.0 71.4 17.9 9.2 11.4 50.9 30.5 8.9 16.8 203.3 6.7 25.8 31.4 14.1 6.9 2.2 12.7 17.2 5.8 140.3 82.7 0.2 2.2 13.6 3.2 0.6 5.1 1.5 17.6 8.7 19.4 12.0 17.9 19.5 27.3 12.1 30.5 10.7 15.2 0.2 1.0 7.6 3.1 5.2 3.7 11.8 30.8 13.7 16.0 3.6 0.1 25.1 2.2 31.3 0.0 0.2 29.7 19.2 19.1 28.7 4.5 0.0 0.1 64.4 0.8 5.1 0.3 5.6 5.2 1.7 18.0 0.1 1.2 3.5 2.0 10.5 22.8 1.7 1.6 10.8 0.1 14.5 11.2 42.4 4.7 19.6 10.9 0.1 0.3 9.4 0.2 3.1 13.6 3.2 0.0 5.1 1.9 0.2 0.1 0.6 2.7 2.2 0.2 0.6 2.0 0.8 0.6 1.2 0.2 0.5 1.5 8.5 7.5 2.1 6.7 9.2 3.2 4.6 4.7 6.0 6.9 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favourable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavourable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavourable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 73.2 57.7 58.6 25.2 13.9 13.0 41.1 48.3 28.5 45.5 64.7 45.0 58.6 74.5 15.7 17.2 55.1 34.6 58.2 41.7 22.1 38.2 52.3 22.2 104.8 5.9 71.6 23.5 9.4 13.8 38.7 9.2 25.9 46.5 63.0 44.3 26.5 136.8 79.2 43.8 32.0 75.6 51.5 60.1 20.6 42.8 50.3 34.2 33.8 52.3 33.1 36.9 36.5 17.3 32.9 37.8 46.2 55.1 32.0 91.3 126.2 14.8 68.2 42.1 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell line enhanced" "Detected in many" "AF22: 49.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA043783: , HPA049934: " "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.4 16.8 49.8 22.3 0.4 1.4 3.9 14.6 9.0 24.0 16.2 9.9 5.4 0.0 5.8 11.8 9.1 25.1 6.5 12.9 19.2 10.0 0.0 10.0 12.0 0.0 0.5 15.2 0.7 0.4 9.9 3.9 7.5 2.9 7.1 15.0 8.9 2.7 0.1 21.8 11.0 22.3 20.0 8.7 3.9 1.9 11.3 15.9 12.6 13.2 12.3 6.1 1.2 3.5 18.8 15.3 11.0 23.8 2.5 9.0 0.0 7.3 6.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 541.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol 540000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (1.30e-4)" "prognostic unfavourable (2.74e-6)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 23.2 76.8 53.8 49.8 70.4 57.5 41.6 56.6 85.9 65.7 31.2 32.1 31.5 26.4 24.7 41.8 76.4 37.9 32.9 94.8 50.1 57.1 60.9 6.1 33.3 39.4 62.5 63.6 26.2 15.6 33.3 28.3 27.1 80.5 34.8 31.9 54.4 47.1 47.5 541.2 51.8 25.1 44.7 34.9 30.7 26.7 29.0 29.4 23.5 23.8 114.4 60.6 53.1 40.9 25.1 79.6 14.9 90.6 11.6 37.4 114.9 81.5 209.8 42.3 50.0 50.9 57.2 35.0 88.5 206.7 142.1 143.9 59.0 100.5 62.1 89.6 165.6 118.9 133.7 180.0 111.4 109.0 63.2 38.0 105.5 48.8 35.5 49.3 82.0 51.9 83.9 109.5 45.0 83.6 9.5 49.8 224.1 50.7 18.4 21.2 52.3 80.1 54.7 135.4 118.3 188.7 105.0 44.0 48.0 115.4 71.2 90.5 49.9 35.9 65.1 161.9 88.6 158.2 160.5 64.0 90.4 54.7 199.3 81.6 158.6 12.6 90.6 14.9 23.5 52.6 22.8 25.1 31.3 23.2 79.6 16.1 27.3 20.2 11.8 11.6 40.2 16.2 37.4 114.9 53.8 70.4 56.6 85.9 50.1 57.1 62.5 63.6 80.5 29.4 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell line enhanced" "Detected in some" "A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: " "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 3.9 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.5 2.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavourable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.4 39.7 33.2 22.6 3.5 6.0 17.8 46.8 27.7 51.9 39.7 26.5 31.7 12.4 18.6 29.8 44.3 37.8 20.0 49.1 22.9 41.9 25.6 51.9 24.3 0.8 12.6 22.2 1.5 2.6 29.4 30.2 29.0 21.3 26.6 48.2 28.2 12.9 19.3 13.0 17.0 13.6 41.5 16.6 23.1 24.7 30.3 24.0 44.5 24.8 16.1 29.7 25.0 17.3 34.3 30.3 28.3 67.4 8.6 22.8 15.3 15.0 31.4 52.3 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 PRR11 FLJ11029 ENSG00000068489 "Proline rich 11" Q96HE9 17 59155499-59204705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023923, HPA052376" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA023923: AB_1855783, HPA052376: " "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "prognostic unfavourable (1.90e-4)" "unprognostic (2.15e-1)" "unprognostic (3.03e-2)" "prognostic unfavourable (1.35e-7)" "prognostic unfavourable (1.79e-4)" "unprognostic (7.22e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (6.18e-4)" "unprognostic (2.80e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.84e-1)" "unprognostic (1.55e-3)" 3.2 1.4 2.8 13.8 4.2 14.9 2.0 0.9 2.8 3.1 4.2 2.2 0.7 6.9 2.0 2.1 10.3 1.7 2.1 1.4 3.1 2.3 1.7 1.1 3.4 9.6 3.2 1.6 1.7 1.0 0.2 0.6 4.8 2.0 1.2 5.5 1.2 2.2 0.5 1.3 2.9 4.8 3.2 5.1 7.3 2.5 2.5 2.1 40.8 1.3 7.7 11.7 2.8 3.2 1.4 3.0 2.5 10.6 0.7 2.0 0.8 27.1 13.1 20.6 6.0 0.6 4.8 8.4 16.9 10.7 17.6 14.0 16.1 18.4 17.6 17.3 12.4 10.0 15.8 17.4 38.6 24.4 10.1 19.3 14.5 10.8 0.2 20.4 8.2 1.1 1.3 19.4 25.8 19.8 10.5 19.2 18.8 21.1 20.0 3.6 8.6 22.1 16.1 31.0 11.3 4.8 7.3 9.0 12.4 14.0 5.1 7.3 13.7 7.9 13.4 36.1 42.3 18.1 30.1 12.4 23.8 17.7 8.0 11.4 35.3 1.0 2.3 2.5 0.8 5.1 0.3 1.4 0.6 1.0 3.0 0.9 0.6 0.8 2.3 0.7 10.6 1.6 2.0 0.8 2.8 4.2 0.9 2.8 3.1 2.3 3.2 1.6 2.0 2.1 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: " "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 46.5 30.2 36.4 26.9 25.4 26.6 39.3 36.7 35.3 59.7 45.0 37.8 38.3 40.6 46.0 31.8 35.6 46.2 32.1 62.8 38.9 20.1 29.7 24.8 40.3 30.8 42.1 28.9 19.7 32.2 30.1 30.5 37.4 44.1 17.6 43.4 42.7 32.8 29.2 29.3 41.6 28.0 63.8 18.1 39.3 47.5 26.2 19.4 32.6 20.5 31.3 42.1 30.8 28.6 33.3 46.7 25.7 37.6 12.5 31.6 45.4 21.5 28.9 30.1 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell line enhanced" "Detected in many" "HEL: 37.1;HMC-1: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.8 5.5 2.7 2.0 1.7 4.2 1.5 0.0 0.3 1.8 13.5 7.6 10.4 2.5 0.0 1.2 37.1 1.8 0.0 2.2 2.1 41.2 1.9 13.0 1.9 6.2 3.9 8.8 0.0 8.6 1.3 0.3 0.0 0.8 0.0 0.0 2.8 1.8 4.2 13.6 0.1 0.8 0.9 3.8 0.1 12.2 4.3 2.8 0.2 3.1 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685732-107713167 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli,Golgi apparatus" Nucleoli "Golgi apparatus" "HPA038708: " "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (9.65e-4)" "prognostic unfavourable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 33.2 25.4 29.4 29.3 32.2 27.9 35.1 32.9 38.7 25.6 29.2 20.3 26.1 17.9 32.9 26.8 33.9 27.5 21.1 18.7 32.9 25.3 31.5 32.3 22.0 29.6 22.9 38.6 35.2 31.1 31.6 23.0 29.8 37.6 27.1 27.5 16.6 26.0 30.5 43.5 32.7 24.2 33.6 33.3 28.7 27.0 36.3 22.1 32.5 27.1 26.8 36.5 30.0 28.1 31.7 21.6 10.9 14.7 18.8 23.8 12.7 23.5 29.6 18.0 17.1 25.4 27.9 23.9 24.8 28.3 35.4 30.0 29.7 11.2 36.4 13.5 38.4 20.7 24.3 26.2 35.1 18.1 27.8 27.7 18.2 34.5 26.1 33.5 19.9 25.0 24.2 32.6 29.3 41.2 36.3 10.3 37.8 26.0 23.4 33.1 21.5 48.6 19.4 21.2 34.0 22.0 33.5 20.4 16.4 20.3 14.7 34.1 26.1 16.7 32.2 27.0 13.7 21.9 28.1 14.8 20.4 28.7 12.0 18.7 23.5 10.9 9.8 7.1 20.2 12.4 18.6 31.7 20.2 21.2 15.9 28.5 17.3 23.8 3.1 18.8 14.7 21.6 21.5 12.7 29.4 32.2 32.9 38.7 32.9 25.3 22.9 38.6 37.6 22.1 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favourable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.5 10.6 30.2 29.2 5.4 9.3 13.3 11.6 4.0 5.6 15.9 18.5 14.1 15.7 15.9 8.6 14.4 18.5 6.6 11.9 8.3 8.7 10.4 13.0 11.5 26.1 18.5 17.7 7.9 11.3 17.9 6.7 11.6 12.9 3.7 22.9 15.5 4.7 7.8 16.7 21.0 21.2 11.4 12.9 9.4 7.8 21.1 9.3 9.1 12.0 15.2 14.8 14.4 7.7 11.9 6.9 17.9 10.5 21.7 18.0 14.4 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favourable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favourable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 18.6 17.1 33.6 24.3 38.8 20.5 26.6 23.6 30.5 20.0 15.4 17.2 17.6 9.9 19.5 26.3 18.7 28.8 19.2 22.5 31.4 22.1 19.5 18.4 19.3 37.1 22.0 26.7 32.6 15.3 16.4 27.0 17.2 25.4 17.2 19.0 18.0 16.2 19.8 45.0 22.6 16.8 18.6 22.1 28.4 15.3 34.6 27.7 25.4 30.7 17.2 37.9 20.3 17.1 46.2 31.5 48.4 18.1 49.3 55.9 65.9 13.0 12.5 21.0 15.7 14.3 13.2 12.7 24.3 16.5 31.1 27.1 17.7 16.2 33.3 15.6 9.6 12.2 29.6 13.7 30.4 24.6 27.5 38.7 16.9 15.2 7.2 51.3 27.3 5.7 7.7 30.0 15.5 13.4 40.4 29.0 18.0 13.3 36.5 22.5 41.1 26.7 24.4 31.1 15.5 11.1 14.2 17.9 17.3 26.8 10.8 21.2 11.2 15.2 8.5 7.7 16.7 41.5 15.9 23.6 52.5 28.9 19.0 45.5 13.9 42.8 18.1 48.4 51.6 14.0 55.9 46.2 48.8 47.3 20.4 39.0 55.8 53.9 18.1 49.3 18.1 31.5 42.5 65.9 33.6 38.8 23.6 30.5 31.4 22.1 22.0 26.7 25.4 27.7 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" HPA056994 Enhanced Supported Cytosol Cytosol "HPA056994: " "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.1 17.7 25.0 17.1 2.2 4.1 24.8 47.7 23.6 34.1 37.1 29.5 14.0 26.8 6.6 14.9 14.3 40.5 24.6 41.8 60.0 15.6 51.6 17.0 26.0 0.1 38.2 24.8 1.4 0.5 41.7 3.5 27.5 21.6 79.5 42.4 22.0 42.2 20.5 20.2 20.7 31.8 54.6 18.4 16.7 22.2 24.8 20.4 39.2 27.9 4.8 15.0 6.9 9.6 26.1 38.0 19.5 66.8 51.6 40.5 54.7 18.5 32.4 37.5 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavourable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 28.8 11.9 17.1 18.0 15.2 17.4 17.8 25.4 21.7 30.9 31.3 24.5 33.7 38.2 15.2 21.0 17.7 34.4 23.0 36.2 15.6 18.6 47.8 14.8 24.6 18.8 44.2 23.4 12.0 18.5 23.5 15.6 17.5 34.2 37.7 37.8 10.4 68.0 40.3 21.3 21.1 51.3 28.0 24.1 29.7 22.0 19.5 15.0 21.5 14.0 15.0 23.2 29.2 14.8 25.9 14.9 27.3 39.5 22.0 39.9 91.2 24.3 37.9 25.5 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA071309: " "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.1 14.0 15.8 14.6 3.3 4.9 14.8 16.8 8.0 15.1 12.8 12.1 14.1 34.7 8.2 8.6 30.8 22.9 10.9 20.5 22.0 9.6 20.9 22.5 7.8 0.9 12.6 21.1 3.2 2.2 20.4 8.3 10.6 16.8 28.6 13.6 8.8 32.9 6.5 13.7 11.0 22.1 45.3 13.0 6.5 6.6 15.0 11.6 20.0 9.4 4.9 18.9 8.6 8.4 18.4 19.4 25.4 21.0 10.5 35.2 20.4 11.9 18.6 22.2 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.2 21.0 32.2 18.5 1.7 3.6 18.2 28.6 15.3 32.9 21.8 23.2 30.5 32.2 12.2 15.6 17.1 34.0 20.8 33.5 14.1 18.4 27.3 17.4 21.4 1.6 36.9 23.2 1.5 1.4 20.7 12.0 24.9 24.6 25.5 31.2 20.6 48.6 52.8 34.8 27.6 34.4 22.8 12.9 18.7 38.2 25.1 15.8 17.2 10.9 8.0 21.4 21.4 14.6 19.2 23.0 17.3 43.1 17.9 23.6 51.6 11.1 35.7 27.1 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "BEWO: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.2 1.7 1.0 1.5 1.2 1.0 25.0 0.5 0.9 1.5 0.9 2.4 3.4 0.7 1.1 1.5 1.3 1.6 1.4 2.4 3.7 0.6 3.0 1.6 1.8 0.8 2.6 4.4 1.1 1.1 1.9 1.3 1.7 2.2 2.6 1.1 1.1 1.0 1.2 0.9 1.0 1.2 0.5 1.6 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 3.7 2.4 2.2 2.8 1.2 2.3 2.1 1.3 0.4 2.8 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.92e-6)" "prognostic unfavourable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 33.7 44.9 57.2 26.1 2.8 5.8 12.7 46.4 25.0 42.7 37.9 21.0 25.9 54.5 23.6 15.7 53.8 43.9 18.5 57.4 29.1 29.3 36.0 28.7 35.1 0.2 50.4 38.3 1.2 1.5 30.0 30.6 22.4 38.9 37.4 46.1 11.7 58.4 33.9 23.7 17.9 49.6 88.8 22.6 10.3 21.6 33.8 24.3 37.4 46.7 14.7 39.2 23.2 14.7 28.2 39.7 32.5 44.5 21.5 24.3 47.6 15.9 34.8 46.9 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133" Supported Enhanced "Nuclear bodies" "Nuclear bodies" "CAB004083: AB_10694558, HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 7.2 12.9 13.4 9.0 20.7 8.9 9.6 21.9 22.9 17.2 10.0 12.5 10.1 5.7 14.6 15.1 7.0 13.8 9.8 10.7 13.9 12.9 8.6 4.1 8.0 7.2 7.1 14.8 15.9 7.4 30.0 34.8 10.7 17.9 11.4 9.5 7.9 9.8 12.3 7.9 8.2 7.2 15.0 7.9 7.2 7.7 18.3 9.3 15.2 16.2 4.9 10.8 11.5 11.1 5.4 3.5 3.7 1.9 2.1 4.8 1.8 6.2 10.7 31.3 19.5 13.0 16.2 7.6 10.8 16.4 15.4 19.6 9.2 7.6 6.7 9.6 18.4 15.6 22.5 13.2 18.4 18.3 7.7 12.8 18.7 5.5 8.5 14.1 18.5 12.5 9.4 20.7 15.5 18.2 12.5 6.0 17.8 4.4 11.0 6.6 20.1 6.6 11.8 11.7 4.4 11.4 14.8 28.4 13.2 15.6 7.0 4.2 14.4 8.0 12.9 16.5 11.2 13.0 9.6 4.8 10.4 15.8 13.7 7.0 8.4 3.7 1.2 2.5 4.1 1.9 3.5 5.4 4.4 4.1 2.9 4.9 4.8 4.4 1.4 2.1 1.2 3.5 3.4 1.8 13.4 20.7 21.9 22.9 13.9 12.9 7.1 14.8 17.9 9.3 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavourable (8.07e-7)" "prognostic unfavourable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 69.6 23.4 28.3 22.1 2.2 4.2 27.3 29.3 16.6 42.6 32.2 49.6 30.1 32.8 17.3 16.3 36.8 32.3 26.6 48.6 14.1 12.5 64.3 22.4 33.8 0.7 24.6 16.6 1.4 1.4 26.7 19.5 22.9 47.5 30.0 33.3 28.6 41.2 19.2 31.5 25.3 23.4 76.4 19.8 11.4 11.4 20.6 13.8 44.8 17.0 13.2 29.5 15.0 15.4 47.8 29.4 21.9 44.9 12.0 20.7 29.4 14.9 87.9 31.0 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavourable (2.99e-5)" "prognostic unfavourable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (9.25e-4)" "unprognostic (1.04e-2)" 10.8 11.6 16.7 8.4 20.9 4.1 15.0 13.8 18.3 11.8 9.5 8.0 6.8 7.5 11.9 10.7 9.6 13.2 8.6 9.9 19.4 9.9 12.9 9.8 9.8 11.8 13.6 14.3 8.8 10.1 14.7 17.7 8.9 14.7 12.0 11.2 7.8 12.0 11.0 18.0 9.9 9.6 14.3 12.9 11.0 10.6 11.7 13.4 9.1 14.9 12.0 10.7 10.2 8.5 5.8 5.0 6.3 6.1 5.1 7.6 4.4 7.4 6.5 5.4 4.2 10.3 5.3 1.3 4.7 5.5 7.0 6.0 3.9 5.2 7.6 6.5 4.8 5.2 7.7 7.7 8.3 7.5 5.8 7.3 6.2 1.3 8.1 0.0 5.9 6.5 10.4 6.8 8.7 5.8 10.2 5.3 4.3 37.1 8.5 3.1 0.0 6.0 2.7 3.6 5.0 6.4 8.1 9.2 7.3 6.9 26.1 9.7 7.4 3.1 4.6 4.8 12.7 3.6 5.3 5.5 7.7 2.9 4.4 2.6 3.9 0.5 6.1 6.3 4.5 4.9 5.6 4.0 6.1 4.6 5.0 5.8 7.6 7.4 2.4 5.1 5.5 1.5 3.7 4.4 16.7 20.9 13.8 18.3 19.4 9.9 13.6 14.3 14.7 13.4 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116276578-116279903 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031970, HPA031971" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092, HPA031971: AB_10602484" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favourable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favourable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 14.0 34.1 38.3 9.8 67.2 18.5 14.4 49.1 64.5 15.2 12.8 9.8 20.1 14.7 13.9 21.4 15.4 20.3 12.9 21.4 34.6 36.6 31.5 23.5 12.9 11.8 21.8 49.8 22.9 17.6 41.3 17.2 9.7 31.1 27.1 11.3 13.3 17.2 22.6 61.6 11.2 12.9 17.1 11.5 15.6 15.3 12.9 12.2 9.8 25.0 15.5 15.2 14.6 12.9 30.7 24.6 52.9 29.4 17.4 36.2 17.0 13.0 12.8 16.5 30.1 29.3 19.4 13.9 20.9 20.9 19.2 22.1 16.5 9.5 27.9 26.3 24.1 23.1 13.0 35.7 20.6 11.3 33.8 11.2 18.9 29.9 18.6 18.3 6.8 22.6 28.0 19.8 19.3 18.2 19.7 21.7 26.7 28.6 12.2 10.8 8.2 12.0 11.3 14.3 15.2 33.2 25.4 14.5 14.3 17.4 23.4 10.0 30.7 22.9 22.0 12.9 11.6 10.4 22.6 11.9 12.9 15.3 21.5 11.9 8.4 52.9 17.8 27.2 24.2 27.7 36.2 25.9 31.7 26.7 14.3 30.7 31.3 30.4 13.5 17.4 29.4 24.6 23.7 17.0 38.3 67.2 49.1 64.5 34.6 36.6 21.8 49.8 31.1 12.2 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: " "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.2 28.8 52.0 24.9 1.4 3.2 29.9 31.2 15.8 51.4 36.9 94.6 45.4 41.6 30.6 14.8 38.8 0.2 33.4 52.5 17.7 27.4 12.8 22.1 24.8 0.4 18.3 32.2 1.0 3.6 34.8 34.1 25.0 0.2 35.4 42.3 64.6 30.2 5.2 31.2 69.0 32.1 47.1 0.2 17.3 13.6 30.0 25.0 49.1 36.0 19.7 36.3 27.0 9.1 46.1 40.3 31.3 60.3 11.2 0.3 46.4 28.0 13.1 43.7 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 6 "B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 22.7 11.4 19.2 12.0 23.3 7.6 15.9 18.8 32.7 22.4 14.5 20.8 7.5 5.9 17.7 31.9 19.7 12.0 18.5 23.4 21.3 21.8 19.1 15.8 16.7 17.7 14.1 19.7 19.0 9.8 15.5 14.4 9.0 20.9 18.2 6.4 8.4 11.2 17.0 32.0 14.8 7.2 22.4 17.6 15.9 11.1 17.8 13.3 14.8 16.8 11.1 14.5 17.0 16.2 14.8 27.1 0.4 18.3 0.8 3.6 5.2 16.7 6.0 16.0 0.3 14.2 15.9 14.5 10.6 18.1 10.0 14.1 1.7 13.8 14.6 7.3 9.3 1.6 11.6 16.5 12.9 0.1 11.6 0.0 7.2 2.0 10.2 0.0 11.7 12.5 17.4 14.3 24.2 9.6 0.8 15.6 9.0 2.6 7.6 3.3 11.3 8.8 16.0 6.2 16.7 9.7 0.4 4.1 8.5 11.7 6.9 0.2 14.7 9.7 8.3 9.9 14.0 6.6 12.0 15.0 4.9 21.5 9.3 6.6 2.7 0.0 15.2 0.0 0.2 17.8 0.3 12.3 0.5 0.2 20.9 14.8 3.6 1.3 0.4 0.8 18.3 27.1 0.2 5.2 19.2 23.3 18.8 32.7 21.3 21.8 14.1 19.7 20.9 13.3 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15, small subunit processome component" Q8TED0 5 73565443-73583377 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Supported "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA044697: " "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 17.1 11.8 6.5 9.4 11.7 38.6 13.2 8.7 12.5 7.5 8.6 10.4 9.3 7.0 11.3 8.7 13.6 10.4 6.7 8.8 12.9 5.6 9.3 12.9 10.2 12.1 11.0 8.0 11.0 9.7 11.8 16.4 8.8 12.5 10.1 10.9 7.5 10.9 6.6 14.5 18.3 10.7 9.9 10.3 11.4 11.9 10.1 10.0 11.4 10.3 13.2 12.8 9.5 9.4 8.3 9.0 4.6 8.0 8.8 10.8 5.4 10.7 11.7 7.9 23.9 6.9 8.2 15.0 12.8 7.5 14.6 16.2 13.0 14.4 24.3 13.0 8.7 9.1 13.5 23.9 22.6 11.9 9.8 11.2 12.4 10.6 8.5 10.1 9.2 8.3 10.8 16.5 18.5 10.0 17.0 13.4 12.3 13.6 15.4 7.2 10.7 6.7 12.3 12.2 23.5 8.7 14.7 8.2 8.8 11.6 9.5 13.5 12.2 7.5 8.1 8.7 12.0 10.1 25.0 9.9 13.1 31.4 13.7 17.5 12.6 2.5 7.0 4.6 9.7 8.0 9.7 8.3 9.8 10.6 9.0 7.2 10.5 10.8 3.8 8.8 7.3 6.5 7.9 5.4 6.5 11.7 8.7 12.5 12.9 5.6 11.0 8.0 12.5 10.0